# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Shagun Singh downgrades Outset Medical (NASDAQ:OM) from Outperform to Sector Perform and lowers the pric...
TD Cowen analyst Joshua Jennings maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $9 to $3.
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.45...